New technique to help brain cancer patients

A new scanning technique developed by Danish and US researchers reveals how susceptible patients with aggressive brain cancer are to the drugs they receive. The research behind the ground-breaking technique has just been published in Nature Medicine.

Each year sees 260 new cases of the most aggressive type of brain cancer in Denmark. Some patients survive only a few months, while others survive for 18 months. Only very few, 3.5%, are alive five years after their diagnosis. A new can now reveal how the brain tumour responds to the drug administered:

"We have developed an MRI technique which reveals how a patient will respond to the treatment that inhibits the growth of new blood vessels to the tumour. The technique allows us to only select the patients who will actually benefit from the treatment and to quickly initiate or intensify other treatments for non-responding patients," says Kim Mouridsen, Associate Professor at Aarhus University and head of the research group Neuroimaging Methods at MINDLab, Aarhus University.

He has developed the new technique together with researchers from Harvard Medical School.

Brain architecture providing important knowledge

Aggressive is usually treated with drugs that inhibit the growth of new blood vessels, as the most aggressive brain tumours are constantly trying to produce new blood vessels to get oxygen. The treatment alleviates the symptoms, but it also increases the efficacy of because it improves oxygenation.

According to Kim Mouridsen, the new technique – Vessel Architectural Imaging – is an important step towards better treatment:

"Getting more knowledge about what the blood vessels in the tumour look like will also give us a better understanding of the mechanisms which are decisive for the efficacy of the treatment. And understanding these mechanisms is precisely what we need to be able to develop and improve the treatment of in general."

More information: Read the scientific article 'Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy' here: www.nature.com/nm/journal/vaop… nt/full/nm.3289.html

add to favorites email to friend print save as pdf

Related Stories

Suffocating tumors could lead to new cancer drugs

Jul 26, 2013

Scientists have discovered a new molecule that prevents cancer cells from responding and surviving when starved of oxygen and which could be developed into new treatments for the disease, according to new research published ...

The secret life of 'tweeting' tumours

Jun 21, 2013

(Medical Xpress)—A breakthrough study led by researchers at Royal Prince Alfred Hospital and the University of Sydney's Brain and Mind Research Institute (BMRI) has revealed how brain tumours communicate with other cells, ...

Recommended for you

Good bowel cleansing is key for high-quality colonoscopy

51 minutes ago

The success of a colonoscopy is closely linked to good bowel preparation, with poor bowel prep often resulting in missed precancerous lesions, according to new consensus guidelines released by the U.S. Multi-Society Task ...

New rules for anticancer vaccines

2 hours ago

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

Mesothelioma risk endures over long-term

3 hours ago

Western Australian researchers have determined the risk of developing mesothelioma continues to increase even 40 years after a person's first exposure to asbestos.

User comments